Skip to content

Evaluation of the Interest of a Specialist in Dermatology for Dermatopediatric Consultations

Evaluation of the Interest of a Specialist in Dermatology for Dermatopediatric Consultations

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03578718
Acronym
HLSkinPed
Enrollment
100
Registered
2018-07-06
Start date
2018-06-25
Completion date
2019-05-01
Last updated
2018-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Collaboration, Dermatologic Disease, Pediatric ALL

Brief summary

Dermatologic diseases, of very different etiology and variable severity, represent a major motivation for consultation (in private consultations and in emergency departments), thus leading pediatricians to frequently turn to dermatologic advice. The principal aim is to estimate the degree of concordance of the main diagnosis between a pediatrician and a pediatric dermatologist. The secondary aims is to estimate the degree of concordance of the treatment, advices and follow-up.

Interventions

None listed

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Under 18 years old * consultating for dermatologic problem in emergency department (1 department) or private pediatric center (1 center) * signed consent * consécutives consultations

Exclusion criteria

* no consent

Design outcomes

Primary

MeasureTime frameDescription
principal diagnosisbaseline% of concordance between diagnosis (dermatologist/pediatric)

Secondary

MeasureTime frameDescription
treamentbaseline% of concordance between treatment (dermatologist/pediatric)
advicesbaseline% of concordance between advices(dermatologist/pediatric)
follow-upbaseline% of concordance between follow-up (dermatologist/pediatric)

Contacts

Primary ContactBURSZTEJN Anne Calire, MCU-PH
ac.bursztejn@chru-nancy.fr+3383157153

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026